HHS launches web-based monoclonal antibody treatment locator 

Posted on: 1/15/21

The Department of Health and Human Services earlier this week released an outpatient treatment locator for monoclonal antibody therapeutics. Hospitals may want to review the locator in light of any confusion it may cause in their communities about how to obtain this treatment.

In November, the Food and Drug Administration issued emergency use authorization for two monoclonal antibody therapeutics to treat mild or moderate COVID-19 in high-risk, non-hospitalized patients. As of Jan. 6, HHS has allocated more than 641,000 treatment courses to states and territories, which have directed delivery of the medicines to more than 3,700 locations. States and territorial health departments must opt in to have information for facilities within their jurisdictions available in the locator. The locator launched with 22 state and territorial health departments opting in, and HHS is encouraging all states and territories to participate.

To view the locator, click here.